U.S. patients seek stem cell treatments in China

06/6/2010 | Washington Post, The

Some U.S. patients with cerebral palsy and other diseases are undergoing experimental stem cell treatments in China, a trend that Western scientists say could jeopardize the health of patients. Moreover, the stem cells used in most clinics in the country are derived from miscarried fetuses, a practice that raises ethical and religious concerns.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA